Eledon Pharmaceuticals, Inc. Common Stock (ELDN) is a publicly traded Healthcare sector company. As of October 26, 2026, ELDN trades at $2.39 with a market cap of $186.90M and a P/E ratio of -4.72. ELDN moved +3.87% today. Year to date, ELDN is +52.32%; over the trailing twelve months it is -30.09%. Its 52-week range spans $1.35 to $4.60. Analyst consensus is strong buy with an average price target of $8.67. Rallies surfaces ELDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ELDN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.39 |
| Market Cap | $186.90M |
| P/E Ratio | -4.72 |
| EPS | $-0.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.60 |
| 52-Week Low | $1.35 |
| Volume | 3.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-45.62M |
| Gross Margin | 0.00% |
3 analysts cover ELDN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.67.